Position in FOLD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$5,439,664
+$74,716 QoQ
Shares Held
376,187
-0.1% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. FOLD ranks #41 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in FOLD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,439,664 | 376,187 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,364,948 | 376,752 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,324,398 | 421,878 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,488,836 | 434,352 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,593,264 | 440,351 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $3,880,738 | 411,968 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $4,401,292 | 412,106 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,311,351 | 434,612 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,890,125 | 415,121 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,713,461 | 402,640 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $5,060,019 | 416,120 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $5,209,234 | 414,748 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $4,739,156 | 427,336 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,803,352 | 393,395 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,888,117 | 372,425 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,638,497 | 338,780 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,707,529 | 285,906 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,610,506 | 312,598 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,020,483 | 316,281 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,981,295 | 309,263 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,031,450 | 306,827 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $7,818,435 | 338,607 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,727,856 | 334,834 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,196,311 | 410,896 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,439,007 | 372,187 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||